glp-1 pediatric obesity Frontiers GLP-1 prescribing among teens with

Description

Quick Answer: Weight loss injections, specifically GLP-1 receptor agonists, do lower cholesterol by reducing triglycerides 15-25%, decreasing LDL cholesterol 3-7%, and modestly increasing HDL cholesterol

In 2024 the journal Diabetes named it as a classic paper

Physician Guidance Each weight loss program begins with an online medical evaluation and is guided by licensed physicians who review health history and determine whether treatment is appropriate

The STEP trials demonstrated 15% to 18% body weight loss and significant reduction in cardiovascular events (SELECT trial, Lincoff et al., New England Journal of Medicine , 2023)

Wegovy is the version approved specifically for chronic weight management, while Ozempic is approved for type 2 diabetes but sometimes is prescribed off-label for weight loss